IDEAS home Printed from https://ideas.repec.org/a/plo/pcbi00/1002371.html
   My bibliography  Save this article

Multi-Scale Modeling of HIV Infection in vitro and APOBEC3G-Based Anti-Retroviral Therapy

Author

Listed:
  • Iraj Hosseini
  • Feilim Mac Gabhann

Abstract

The human APOBEC3G is an innate restriction factor that, in the absence of Vif, restricts HIV-1 replication by inducing excessive deamination of cytidine residues in nascent reverse transcripts and inhibiting reverse transcription and integration. To shed light on impact of A3G-Vif interactions on HIV replication, we developed a multi-scale computational system consisting of intracellular (single-cell), cellular and extracellular (multicellular) events by using ordinary differential equations. The single-cell model describes molecular-level events within individual cells (such as production and degradation of host and viral proteins, and assembly and release of new virions), whereas the multicellular model describes the viral dynamics and multiple cycles of infection within a population of cells. We estimated the model parameters either directly from previously published experimental data or by running simulations to find the optimum values. We validated our integrated model by reproducing the results of in vitro T cell culture experiments. Crucially, both downstream effects of A3G (hypermutation and reduction of viral burst size) were necessary to replicate the experimental results in silico. We also used the model to study anti-HIV capability of several possible therapeutic strategies including: an antibody to Vif; upregulation of A3G; and mutated forms of A3G. According to our simulations, A3G with a mutated Vif binding site is predicted to be significantly more effective than other molecules at the same dose. Ultimately, we performed sensitivity analysis to identify important model parameters. The results showed that the timing of particle formation and virus release had the highest impacts on HIV replication. The model also predicted that the degradation of A3G by Vif is not a crucial step in HIV pathogenesis. Author Summary: According to UNAIDS (The Joint UN Programme on HIV/AIDS) and WHO, HIV/AIDS has killed more than 25 million people worldwide since its recognition in 1981. Recently, APOBEC3G, a member of the APOBEC family, has been shown to be a potent inhibitor of HIV infection. In contrast, a viral protein, called Vif, is known to protect the virus by binding to APOBEC3G and causing the degradation of this enzyme. We have developed a computational model to simulate in vitro experiments that include A3G-Vif interactions at the intracellular level and T cell-HIV dynamics at the multicellular level. Experimental data were used to establish system parameters and also to validate predictions of our models. We studied various drugs targeting APOBEC3G and Vif pathways to find the optimum therapeutic approach against HIV replication. Our model predicted that a mutated form of APOBEC3G that does not bind to Vif performs significantly better at suppressing HIV replication compared to other drugs. We also found that the drug should be administered shortly after infection and it must be available to all cells in order to be effective.

Suggested Citation

  • Iraj Hosseini & Feilim Mac Gabhann, 2012. "Multi-Scale Modeling of HIV Infection in vitro and APOBEC3G-Based Anti-Retroviral Therapy," PLOS Computational Biology, Public Library of Science, vol. 8(2), pages 1-17, February.
  • Handle: RePEc:plo:pcbi00:1002371
    DOI: 10.1371/journal.pcbi.1002371
    as

    Download full text from publisher

    File URL: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1002371
    Download Restriction: no

    File URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1002371&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pcbi.1002371?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Ya-Lin Chiu & Vanessa B. Soros & Jason F. Kreisberg & Kim Stopak & Wes Yonemoto & Warner C. Greene, 2005. "Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells," Nature, Nature, vol. 435(7038), pages 108-114, May.
    2. Hui Zhang & Bin Yang & Roger J. Pomerantz & Chune Zhang & Shyamala C. Arunachalam & Ling Gao, 2003. "The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA," Nature, Nature, vol. 424(6944), pages 94-98, July.
    3. Ann M. Sheehy & Nathan C. Gaddis & Jonathan D. Choi & Michael H. Malim, 2002. "Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein," Nature, Nature, vol. 418(6898), pages 646-650, August.
    4. David D. Ho & Avidan U. Neumann & Alan S. Perelson & Wen Chen & John M. Leonard & Martin Markowitz, 1995. "Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-1 Infection," Working Papers 95-01-002, Santa Fe Institute.
    5. Eddy Arnold & Stefan G. Sarafianos, 2008. "An HIV secret uncovered," Nature, Nature, vol. 453(7192), pages 169-170, May.
    6. Alan S. Perelson & Avidan U. Neumann & Martin Markowitz & John M. Leonard & David D. Ho, 1996. "HIV-1 Dynamics In Vivo: Virion Clearance Rate, Infected Cell Lifespan, and Viral Generation Time," Working Papers 96-02-004, Santa Fe Institute.
    7. Tae-Wook Chun & Lucy Carruth & Diana Finzi & Xuefei Shen & Joseph A. DiGiuseppe & Harry Taylor & Monika Hermankova & Karen Chadwick & Joseph Margolick & Thomas C. Quinn & Yen-Hong Kuo & Ronald Brookme, 1997. "Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection," Nature, Nature, vol. 387(6629), pages 183-188, May.
    8. Ashley T. Haase & Keith Henry & Mary Zupancic & Gerlad Sedgewick & Russell A. Faust & Holly Melroe & Winston Cavert & Kristin Gebhard & Katherine Staskus & Zhi-Qiang Zhang & Peter J. Dailey & Henry H., 1996. "Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue," Working Papers 96-07-045, Santa Fe Institute.
    9. Bastien Mangeat & Priscilla Turelli & Gersende Caron & Marc Friedli & Luc Perrin & Didier Trono, 2003. "Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts," Nature, Nature, vol. 424(6944), pages 99-103, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Vanessa B Soros & Wes Yonemoto & Warner C Greene, 2007. "Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H," PLOS Pathogens, Public Library of Science, vol. 3(2), pages 1-16, February.
    2. González, Ramón E.R. & Coutinho, Sérgio & Zorzenon dos Santos, Rita Maria & de Figueirêdo, Pedro Hugo, 2013. "Dynamics of the HIV infection under antiretroviral therapy: A cellular automata approach," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 392(19), pages 4701-4716.
    3. Hanjing Yang & Kyumin Kim & Shuxing Li & Josue Pacheco & Xiaojiang S. Chen, 2022. "Structural basis of sequence-specific RNA recognition by the antiviral factor APOBEC3G," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    4. Arshad, Sadia & Defterli, Ozlem & Baleanu, Dumitru, 2020. "A second order accurate approximation for fractional derivatives with singular and non-singular kernel applied to a HIV model," Applied Mathematics and Computation, Elsevier, vol. 374(C).
    5. Patric Jern & Rebecca A Russell & Vinay K Pathak & John M Coffin, 2009. "Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance," PLOS Pathogens, Public Library of Science, vol. 5(4), pages 1-9, April.
    6. Sun, Hongquan & Li, Jin, 2020. "A numerical method for a diffusive virus model with general incidence function, cell-to-cell transmission and time delay," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 545(C).
    7. Wang, Jinliang & Guo, Min & Liu, Xianning & Zhao, Zhitao, 2016. "Threshold dynamics of HIV-1 virus model with cell-to-cell transmission, cell-mediated immune responses and distributed delay," Applied Mathematics and Computation, Elsevier, vol. 291(C), pages 149-161.
    8. Singh, Harendra, 2021. "Analysis of drug treatment of the fractional HIV infection model of CD4+ T-cells," Chaos, Solitons & Fractals, Elsevier, vol. 146(C).
    9. A. Adam Ding & Hulin Wu, 2000. "A Comparison Study of Models and Fitting Procedures for Biphasic Viral Dynamics in HIV-1 Infected Patients Treated with Antiviral Therapies," Biometrics, The International Biometric Society, vol. 56(1), pages 293-300, March.
    10. Yangxin Huang & Dacheng Liu & Hulin Wu, 2006. "Hierarchical Bayesian Methods for Estimation of Parameters in a Longitudinal HIV Dynamic System," Biometrics, The International Biometric Society, vol. 62(2), pages 413-423, June.
    11. Jianwei Chen, 2010. "Modelling long‐term human immunodeficiency virus dynamic models with application to acquired immune deficiency syndrome clinical study," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 59(5), pages 805-820, November.
    12. Naik, Parvaiz Ahmad & Zu, Jian & Ghoreishi, Mohammad, 2020. "Estimating the approximate analytical solution of HIV viral dynamic model by using homotopy analysis method," Chaos, Solitons & Fractals, Elsevier, vol. 131(C).
    13. Hulin Wu & A. Adam Ding, 1999. "Population HIV-1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials," Biometrics, The International Biometric Society, vol. 55(2), pages 410-418, June.
    14. Hannah O. Ajoge & Tyler M. Renner & Kasandra Bélanger & Matthew Greig & Samar Dankar & Hinissan P. Kohio & Macon D. Coleman & Emmanuel Ndashimye & Eric J. Arts & Marc-André Langlois & Stephen D. Barr, 2023. "Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    15. Rebecca M. D'Amato & Richard T. D'Aquila & Lawrence M. Wein, 2000. "Management of Antiretroviral Therapy for HIV Infection: Analyzing When to Change Therapy," Management Science, INFORMS, vol. 46(9), pages 1200-1213, September.
    16. Wein, Lawrence M. & D'Amato, Rebecca M. & Perelman, Alan S., 1947-, 1997. "Mathematical considerations of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads," Working papers WP 3939-97., Massachusetts Institute of Technology (MIT), Sloan School of Management.
    17. Guo, Wenjuan & Zhang, Qimin, 2021. "Explicit numerical approximation for an impulsive stochastic age-structured HIV infection model with Markovian switching," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 182(C), pages 86-115.
    18. Christian L Althaus & Beda Joos & Alan S Perelson & Huldrych F Günthard, 2014. "Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells," PLOS Computational Biology, Public Library of Science, vol. 10(10), pages 1-11, October.
    19. Fumiaki Ito & Ana L. Alvarez-Cabrera & Kyumin Kim & Z. Hong Zhou & Xiaojiang S. Chen, 2023. "Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    20. Max A. Stafford & Yunzhen Cao & David D. Ho & Lawrence Corey & Crystal L. Mackall & Ronald E. Gress & Alan S. Perelson, 1999. "Modeling Plasma Virus Concentration and CD4+ T Cell Kinetics during Primary HIV Infection," Working Papers 99-05-036, Santa Fe Institute.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pcbi00:1002371. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ploscompbiol (email available below). General contact details of provider: https://journals.plos.org/ploscompbiol/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.